CDKN2A and BAP1-related tumor predisposition syndrome: Clinicians and genetic professionals should be cognizant of this expanded range of phenotypes and consider CDKN2A as a candidate gene for tumor predisposition syndrome in individuals and families presenting with such broad spectrum of cancers.